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Summary The relationship between the number of cigarettes smoked per day and the incidence of lung cancer is linear but, from the
multistage model of carcinogenesis, it should be quadratic (upwards curving). We investigated this anomaly in a study of 11 403 male never
smokers and current smokers in whom carboxyhaemoglobin (COHb) was measured in all and serum cotinine in 1175. The relationship
between the biochemical markers and the reported number of cigarettes per day was approximately linear up to 20 cigarettes per day as
expected. But above 20 cigarettes per day the marker levels increased less steeply and were 35% lower than expected in men who smoked
more than 40 cigarettes per day. Less smoke is inhaled from each cigarette by men with high daily cigarette consumption than by men with
lower consumption. Allowance for this transforms the observed linear dose-response relationship into one consistent with the expected
quadratic relationship. The anomaly is explained by the observation that heavier smokers inhale less smoke from each cigarette.
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There is an approximately linear relationship between the number
of cigarettes per day that a person reports smoking and the age-
specific risk of lung cancer - as consumption doubles, risk
doubles. Armitage (1971) and Doll and Peto (1978) pointed out
that this was surprising. The multistage model of carcinogenesis
proposes that a cell undergoes malignant transformation only after
it has undergone a certain number of heritable changes, each of
low occurrence rate (Day and Brown, 1980). Ifthere are k stages,
it can be shown that the incidence of a cancer after time t will be
proportional to t1-', and so the plotofthe logarithm ofage-specific
incidence on the logarithm of time will be a straight line with
slope k-i. For lung cancer, the incidence increases to the fourth
power of age, and hence there are an estimated five stages.
Epidemiological observations indicate that smoking affects two of
the stages; an early stage because many years elapse between
starting smoking and developing an appreciable risk of lung
cancer, and a late stage because risk falls rapidly in a person who
stops smoking relative to a person who does not (Doll and Peto,
1978; Day and Brown, 1980). Ifoneperson smoked twice as many
cigarettes per day as another, other factors being equal, the rate
of occurrence of both the early stage and the late stage should
therefore be approximately doubled in the heavier smoker. As
consumption doubles, risk should increase fourfold; the risk of
lung cancer should be related to the square ofthe number ofciga-
rettes smoked perday (the squre or second power as two stages are
affected) (Doll and Peto, 1978). Thus, a linear relationship is
observed but a quadratic relationship is expected. We report an
investigation into this anomaly using two biochemical markers
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of tobacco smoke intake, carboxyhaemoglobin (COHb) and
serum cotinine.
METHODS
Our study consisted of21 520 men aged 35-64 years who attended
the British United Provident Association (BUPA) Medical Centre
between 1975 and 1982; the cohort has been described before
(Wald et al, 1994). At the time of the visit, a detailed smoking
history was obtained from each man, COHb was measured using
whole blood on a CO-Oximiter (Wald et al, 1978) and serum
samples were stored at -40°C. The present study is of the 11 403
men who had never smoked any form of tobacco or were current
smokers of manufactured cigarettes only (not pipes, cigars or
hand-rolled cigarettes). A COHb measurement was available
for all 11 403 men; for 1175 men, cotinine concentration was
measured by radioimmunoassay (Langone and Van Vunakis,
1982) on the stored serum samples. The distribution of cotinine
measurements was log transformed to correct for skewness.
We calculated the relationship between COHb and the number
ofcigarettes smoked per day that would be expected ifthe smoke
from each cigarette was inhaled to the same intensity irrespective
of the number of cigarettes smoked per day. Experimentally, the
effect of smoking one cigarette is to increase COHb by a constant
increment that is independent ofthe baseline COHb (Coburn et al,
1965; Lawther, 1975), which is about one percentage point (e.g.
from 2% to 3%, or 8% to 9%) (Lawther, 1975; Wald et al, 1975).
When smoking ceases COHb converts to Hb in an exponential
manner, with aCOHb half-life that varies with activity but is about
4 h on average in smokers (Cobum et al, 1965; Lawther, 1975;
Wald et al, 1975). Innon-smokers, COHb is about 0.8%; ifit isx%
immediately after smoking, COHb will decline according to the
exponential function, COHb = (x-0.8) 0.51/4 + 0.8, where tis time
in h. If one cigarette is smoked at time t, COHb will increase by
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Figure 1 Mean COHb (with 95% confidence limits) according to reported
number of manufactured cigarettes smoked per day in 11 403 men. The
straight line connects the average COHb levels corresponding to daily
cigarette consumption of 0 and of 20 (the average in smokers)
1% from thepercentage given by the above formula. Fromthis, we
calculated expected values of COHb according to time of day
(midway through smoking each cigarette) for three hypothetical
smokers who smoke 10, 20 and40cigarettes in aday ateven inter-
vals over 16 h. We calculated the steady-state values after many
days ofsmoking, taking into account the decline in COHb overthe
8 h of sleeping such that the excess above background levels on
waking in the morning is a quarter that at the end of the previous
evening.
RESULTS
Figure 1 shows the observed relationship between COHb and the
reported number ofcigarettes smoked per day in the 11 403 men.
There is an approximate linear relationship between COHb and
cigarette consumption up to 20 cigarettes per day. Above 20 ciga-
rettes per day, however, the increase in COHb is proportionately
smaller.
Time (h)
Figure 2 Expected values of COHb, if the smoke from all cigarettes was
inhaled to the same intensity, in persons who smoke 0, 10, 20 and 40
cigarettes at even intervals each day according to number of hours since
waking
Figure 2 shows the expected relationship between COHb and
the number of cigarettes smoked in a day if the smoke from each
cigarette were inhaled to the same extent. In smokers of 40 ciga-
rettes per day, at any time of day, the excess in COHb above the
background level in non-smokers is double that in smokers of 20
cigarettes per day which, in turn, is double that in smokers of 10.
The expected relationship between COHb and the numberofciga-
rettes smoked per day is therefore linear, even though the rise in
COHb overthe day is not linear. The value ofabout 5% after4 h in
smokers of 20 cigarettes per day corresponds to the average
observed value in smokers of 20 per day (measurements were
made on average about 4 h after waking).
In Figure 1, the straight line connects the average COHb levels
corresponding to daily cigarette consumption of 0 and of 20 (the
average in smokers), and the dots show the average COHb level
(with 95% confidence limits) corresponding to a given reported
number ofcigarettes smoked per day. The point corresponding to
this COHb level on the straight line defines the expected number
of cigarettes smoked per day if the dose-response relationship
with COHb were linear (that is, ifall smokers inhaled to the same
intensity). Table 1 shows these expected, or adjusted, values for
Table 1 Dose-response relationship between the reported number of cigarettes smoked per day and the concentration of biochemical markers of tobacco
smoke intake (COHb and cotinine)
Reported no. of cigarettes per day Mean COHb Geometric mean No of cigarettes per dayadjusteds for:
serum cotinine
Category Mean (%) (ng mi-1) COHb Cotinine Average of both
0 0 0.79 1.4 0.0 0.0 0.0
1-9 5.0 1.74 44.7 4.8 3.5 4.1
10-14 11.0 3.07 130.3 11.5 10.4 10.9
15-19 15.6 4.09 247.2 16.6 19.8 18.2
20 20 4.77 249.4 20.0 20.0 20.0
20-24 20.1 4.80 251.9 20.2 20.2 20.2
25-29 25.2 5.65 301.0 24.4 24.2 24.3
30-34 30.1 5.90 286.3 25.7 23.0 24.3
35-39 35.2 6.00 337.9 26.2 27.1 26.7
40+ 43.7 6.54 343.4 28.9 27.6 28.2
aAdjusted by taking the no. of cigarettes per day corresponding to the marker concentration from the straight line connecting marker concentrations for 0 and 20
cigarettes perday (see Figure 1).
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Figure 3 Estimates (with 95% confidence limits) from the US veterans study
(Kahn, 1966) of lung cancer mortality in current smokers relative to that in
never smokers, according to reported cigarette consumption and adjusted
(from Table 1) cigarette consumption
specified reported numbers ofcigarettes smoked per day and also
shows the same data from the serum continine measurements. The
adjusted values of daily cigarette consumption are similar for the
two biochemical markers, COHb and cotinine, and the final
column in Table 1 shows the average ofthese two estimates.
Figure 3 shows the relative risk of lung cancer death plotted
against daily cigarette consumption in the US Veterans Study, the
largest cohort study ofsmoking andlung cancer(Kahn, 1966). The
categories of cigarette consumption are displayed as both the
reported consumption and the adjusted consumption based on the
biochemical markers (Table 1). The relationship between lung
cancer mortality and reported cigarette consumption is linear. The
relationship between lung cancer mortality and adjusted cigarette
consumption, however, is inconsistent with a linear relationship
(as evident from the 95% confidence limits on the risk estimates).
It is consistent with a quadratic relationship (with incidence
increasing more steeply at higher consumption levels); the fit was
poor in only the lowest smoking category, in which risk was
greater than predicted from the quadratic model. The findings in
other large cohort studies of smoking and lung cancer (Hammond
and Horn, 1958; Hammond, 1966; Doll and Peto, 1976; Kuller et
al, 1991) are similar. The greater than expected risk in the lowest
consumption category may have arisen because some smokers had
reduced their cigarette consumption before recruitment to the
study but few had increased it. Smokers who had reduced their
consumption will be most prevalent in the lowest consumption
category, and the higher than expected risk in this group may be
due to their previous heavier smoking.
DISCUSSION
Our results explain the anomaly that, while the incidence of lung
cancer is expected to increase with the square of the number of
cigarettes smoked per day, the observed relationship is linear. The
key observation that provides the explanation is that the relation-
ship between the number of cigarettes smoked per day and the
concentration of biochemical markers of tobacco smoke intake is
not linear, a finding that was reported previously (Vogt et al, 1979;
Rees et al, 1980; Vesey et al, 1982; Hill et al, 1983; Parish et al,
1995). It would be linear if heavier and lighter smokers, on
average, inhaled the smoke from each cigarette to the same extent,
but smokers of more than about 20 cigarettes per day inhale rela-
tively less from each cigarette - a plausible adaptive response to
heavy cigarette consumption. Theeffectmay alsobepartlybecause
ofexaggeration by smokers who reportheavy consumption.
The overall effect is substantial; in men who reported smoking
40 or more cigarettes per day (average 43.7), for example, the
expected number of cigarettes per day from our marker data,
assuming a constant extent ofinhaling, was 35% less (28.2). With
adjustment for the biochemical markers, the dose-response rela-
tionship between tobacco consumption and lung cancer is consis-
tent with the expected quadratic relationship.
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